title: Treatment of autistic disorder.
abstract: OBJECTIVE
  To present an overview of a variety of treatment approaches in individuals with autistic disorder.
  
  
  METHODS
  Selected studies and articles are reviewed.
  
  
  RESULTS
  In the past three decades, great progress has been made in the treatment of autistic disorder, particularly in the area of education and parental involvement, with the objective to transfer to home and in other situations learning acquired in school. A role for psychoactive agents, when combined with psychosocial treatments, has been identified.
  
  
  CONCLUSIONS
  Although considerable advances have been made in a variety of interventions-educational, psychosocial, and biological-knowledge about the comparative and combined efficacy of the various treatment modalities is lacking. From the parents' perspective, particularly, support and continuity of services require improvement.
authors.affiliation: Department of Psychiatry, New York University Medical Center, NY 10016, USA.
authors.forename: M
authors.initials: M
authors.lastname: Campbell
authors.forename: E
authors.initials: E
authors.lastname: Schopler
authors.forename: J E
authors.initials: JE
authors.lastname: Cueva
authors.forename: A
authors.initials: A
authors.lastname: Hallin
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use; D001321:Autistic Disorder / Q000188:drug therapy* / Q000628:therapy*; D001521:Behavior Therapy; D002997:Clomipramine / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D005277:Fenfluramine / Q000627:therapeutic use; D006801:Humans; D009271:Naltrexone / Q000627:therapeutic use; D012050:Rehabilitation, Vocational; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013070:Speech Therapy
chemical_list: D014150:Antipsychotic Agents; D002997:Clomipramine; D003000:Clonidine; D005277:Fenfluramine; D009271:Naltrexone; D017367:Selective Serotonin Reuptake Inhibitors